Back
Neurocrine Biosciences Stock Price Chart
Meet the founder that's revolutionizing smartphones
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
37
NBIX
Neurocrine Biosciences
Last Price:
$102.86
Seasonality Move:
6.8%
7 Day Trial
ALL ACCESS PASS
$
7
Crowdfunding to IPO: Nasdaq's Next Breakout?
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NBIX is experiencing buying pressure, which is a positive indicator for future bullish movement.
Neurocrine Biosciences Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 112.41 | Sell |
| 20-day SMA: | 111.42 | Sell |
| 50-day SMA: | 123.79 | Sell |
| 200-day SMA: | 129.54 | Sell |
| 8-day EMA: | 110.77 | Sell |
| 20-day EMA: | 112.86 | Sell |
| 50-day EMA: | 119.28 | Sell |
| 200-day EMA: | 126.67 | Sell |
Neurocrine Biosciences Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -2.9 | Sell |
| Relative Strength Index (14 RSI): | 37.19 | Sell |
| Chaikin Money Flow: | 1287868 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (109.22 - 115.56) | Sell |
| Bollinger Bands (100): | (114.17 - 140.17) | Sell |
Neurocrine Biosciences Technical Analysis
| Mar 20 | Mar 21 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 28 | Mar 31 | Apr 1 | Apr 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 20 | 21 | 24 | 25 | 26 | 27 | 28 | 31 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Neurocrine Biosciences Stock
Is Neurocrine Biosciences Stock a Buy?
-
Neurocrine Biosciences share price is 108.31 while NBIX 8-day simple moving average is 112.41, which is a Sell signal.
-
The stock price of NBIX is 108.31 while Neurocrine Biosciences 20-day SMA is 111.42, which makes it a Sell.
-
Neurocrine Biosciences 50-day simple moving average is 123.79 while NBIX share price is 108.31, making it a Sell technically.
-
NBIX stock price is 108.31 and Neurocrine Biosciences 200-day simple moving average is 129.54, creating a Sell signal.
NBIX Technical Analysis vs Fundamental Analysis
Sell
37
Neurocrine Biosciences (NBIX)
is a Sell
Is Neurocrine Biosciences a Buy or a Sell?
-
Neurocrine Biosciences stock is rated a SellThe current Neurocrine Biosciences [NBIX] share price is $108.31. The Score for NBIX is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
Neurocrine Biosciences Stock Info
Market Cap:
10.8B
Price in USD:
108.31
Share Volume:
1.4M
Neurocrine Biosciences 52-Week Range
52-Week High:
157.98
52-Week Low:
105.18
Sell
37
Neurocrine Biosciences (NBIX)
is a Sell
Neurocrine Biosciences Share Price Forecast
-
What is the Neurocrine Biosciences stock price today?The Neurocrine Biosciences stock price is 108.31 USD today.
-
Will NBIX stock go up or go down?Neurocrine Biosciences> share price is forecast to RISE/FALL based on technical indicators
-
Is Neurocrine Biosciences overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Neurocrine Biosciences is overvalued.
Is Neurocrine Biosciences Stock a Buy?
-
Neurocrine Biosciences share price is 108.31 while NBIX 8-day exponential moving average is 110.77, which is a Sell signal.
-
The stock price of NBIX is 108.31 while Neurocrine Biosciences 20-day EMA is 112.86, which makes it a Sell.
-
Neurocrine Biosciences 50-day exponential moving average is 119.28 while NBIX share price is 108.31, making it a Sell technically.
-
NBIX stock price is 108.31 and Neurocrine Biosciences 200-day simple moving average is 126.67, creating a Sell signal.
Fundamental Analysis of Neurocrine Biosciences
Is Neurocrine Biosciences a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.11 per share, an increase next quarter of $0.52 per share, a decrease this year of $0.39 per share, and an increase next year of $2.61 per share.
Technical Analysis of Neurocrine Biosciences
Should I short Neurocrine Biosciences stock?
-
NBIX Moving Average Covergence Divergence (MACD) indicator is -2.9, suggesting Neurocrine Biosciences is a Sell
-
Neurocrine Biosciences Relative Strength Index (RSI) is 37.19, which suggest Neurocrine Biosciences is oversold
-
The Bollinger Bands (25) for Neurocrine Biosciences is (109.22 - 115.56), which suggest Neurocrine Biosciences is a Sell
-
The Bollinger Bands (100) for Neurocrine Biosciences is (114.17 - 140.17), which suggest Neurocrine Biosciences is a Sell
* Neurocrine Biosciences stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.